Moderna’s COVID-19 vaccine still effective five months after second dose: Study

Written by admin
Los Angeles
US drugmaker Moderna’s anti-Covid-19 vaccine is 87 percent effective in preventing infection, 95 percent against serious disease and 98 percent in avoiding the risk of death. This has been claimed in a study. The research, published in ‘The Lancet Regional Health – America’s Journal’, evaluated the five-month efficacy of Moderna’s COVID-19 m-RNA vaccine as an observational study. The Moderna-funded study included 352,878 people who were vaccinated and the same number of people who were not vaccinated, based on age, gender and race. Katia Brooksvoort, Assistant Investigator at Kaiser Permanente, an integrative health care organization in Southern California, US, said, ‘This research shows the high efficacy of Moderna’s COVID-19 vaccine in reducing the risk of infection, hospitalization and death from COVID-19. provides proof of.’ “One of the important aspects of the study was that it included more than 700,000 adults who were racially and ethnically diverse,” Brooksvoort said. These included people with severe chronic diseases, immunocompromised individuals. In the study, vaccinated people were given two doses of Moderna’s vaccine from December 18, 2020, to March 31, 2021. It was found that the efficacy of the vaccine against COVID-19 was 87 percent. He said that 13 people who were vaccinated and 182 infected patients who were not vaccinated were hospitalized, in which one patient who was vaccinated and 25 patients who did not get vaccinated died.

About the author


Leave a Comment